Literature DB >> 11166964

The role of neuroinflammation and neuroimmune activation in persistent pain.

J A DeLeo1, R P Yezierski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11166964     DOI: 10.1016/s0304-3959(00)00490-5

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


× No keyword cloud information.
  197 in total

Review 1.  Recent developments: management of pain.

Authors:  Anita Holdcroft; Ian Power
Journal:  BMJ       Date:  2003-03-22

Review 2.  New and emerging pharmacological targets for neuropathic pain.

Authors:  Donald C Manning
Journal:  Curr Pain Headache Rep       Date:  2004-06

3.  Spinal injection of TNF-α-activated astrocytes produces persistent pain symptom mechanical allodynia by releasing monocyte chemoattractant protein-1.

Authors:  Yong-Jing Gao; Ling Zhang; Ru-Rong Ji
Journal:  Glia       Date:  2010-11-15       Impact factor: 7.452

4.  Tachykinin NK₁ receptor antagonist co-administration attenuates opioid withdrawal-mediated spinal microglia and astrocyte activation.

Authors:  Suneeta Tumati; Tally M Largent-Milnes; Attila I Keresztes; Takashi Yamamoto; Todd W Vanderah; William R Roeske; Victor J Hruby; Eva V Varga
Journal:  Eur J Pharmacol       Date:  2012-06-05       Impact factor: 4.432

5.  Repeated morphine treatment-mediated hyperalgesia, allodynia and spinal glial activation are blocked by co-administration of a selective cannabinoid receptor type-2 agonist.

Authors:  Suneeta Tumati; Tally M Largent-Milnes; Attila Keresztes; Jiyang Ren; William R Roeske; Todd W Vanderah; Eva V Varga
Journal:  J Neuroimmunol       Date:  2012-01-30       Impact factor: 3.478

6.  Chronic low back pain, sleep disturbance, and interleukin-6.

Authors:  Kathi L Heffner; Christopher R France; Zina Trost; H Mei Ng; Wilfred R Pigeon
Journal:  Clin J Pain       Date:  2011-01       Impact factor: 3.442

Review 7.  Chemokines: integrators of pain and inflammation.

Authors:  Fletcher A White; Sonia K Bhangoo; Richard J Miller
Journal:  Nat Rev Drug Discov       Date:  2005-10       Impact factor: 84.694

Review 8.  Role of decreased sensory neuron membrane calcium currents in the genesis of neuropathic pain.

Authors:  Quinn H Hogan
Journal:  Croat Med J       Date:  2007-02       Impact factor: 1.351

Review 9.  Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain.

Authors:  J Guindon; A G Hohmann
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

10.  Effect of pioglitazone on neuropathic pain and spinal expression of TLR-4 and cytokines.

Authors:  Hongbin Jia; Shuangshuang Xu; Qingzhen Liu; Jian Liu; Jianguo Xu; Weiyan Li; Yi Jin; Qing Ji
Journal:  Exp Ther Med       Date:  2016-09-01       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.